OKOksana A. Koreshkova

Oksana A. Koreshkova

*This is an algorithmically generated author record based on publicly available information.

Oksana A. Koreshkova has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Organization of External Quality Control Testing for Plague Using Encrypted Sample Panels

    by M. A. Senichkina, I. N. Sharova, S. A. Portenko, K. D. Blinova, O. A. Koreshkova, A. P. Smolina, S. A. Shcherbakova, V. V. Kutyrev

    The aim of the work was to evaluate the results of external quality control of molecular-genetic and immunological testing for plague in anti-plague laboratories using encrypted control panels. Materials and methods. A total of 19 anti-plague institutions participated in the external quality control program. The quality of laboratory testing was assessed using polymerase chain reaction (PCR) and fluorescent antibody method (FAM) with encrypted panels, in which the composition of samples was unknown to the participating laboratories. The PCR panels contained dried DNA preparations of Yersinia pestis EV NIIEG strain as positive samples, as well as DNA of Yersinia pseudotuberculosis and Escherichia coli at concentrations of at least 1 ng and a 15 % sucrose solution as negative samples. For assessment of plague detection applying fluorescent antibody method, fixed smears of the same microorganisms ( Y. pestis EV NIIEG, Y. pseudotuberculosis and E. coli ) were used at concentrations of 1·10 6 microbial cells per milliliter. Results and discussion. The analysis of external quality control results obtained from anti-plague laboratories was performed over the period of 2011–2025. The proportion of false-positive results obtained through FAM was 0.7 %, while false-negative results accounted for 0.47 %. In PCR-based detection, false-positive results accounted for 1.27 % and false-negative results for 0.36%. The analysis made it possible to identify potential sources of analytical errors in plague detection and to determine measures aimed at their elimination. To prevent erroneous results, it is necessary to implement internal quality control procedures, ensure timely procurement of diagnostic reagents, maintain proper condition of laboratory equipment, strictly follow manufacturers’ recommendations regarding the use of validated instruments, and regularly confirm personnel qualifications. External quality control of plague diagnostics in anti-plague institutions using encrypted panels containing Y. pestis samples that simulate real biological samples is an effective tool for monitoring laboratory performance, ensuring the quality of laboratory testing, and maintaining the reliability of diagnostic results.

  • Open Access

    Genetic characteristics of Vibrio cholerae non-O1/non-O139 and Vibrio paracholerae strains circulating in the Volga River near Saratov

    by Svetlana P. Zadnova, Nadezhda B. Cheldyshova, Daria L. Kusmartseva, Darya A. Rybalchenko, Danil A. Sergutin, Andrey V. Boyko, Andrey V. Kazantsev, Oksana A. Koreshkova, Andrey V. Fedorov, Yaroslav M. Krasnov, et al.

    Introduction. The relevance of this study is determined by the critical necessity for molecular genetic monitoring of major river systems to control the spread of pathogenic non-toxigenic vibrios, including the recently discovered Vibrio paracholerae species in the Russian Federation, against the backdrop of increasing climatic and anthropogenic risks. Objective. To study the genetic characteristics of V. cholerae non-O1/non-O139 and V. paracholerae strains isolated from the Volga River near Saratov. Materials and methods. Twenty-one strains of vibrios isolated in 2024 were studied. Biochemical properties were assessed using the api 20 E kit. Sequencing was performed on the MGI DNBSEQ-G50 platform. Blast v. 2.15.0 and BioEdit v. 7.0.9.0 algorithms were used for bioinformatics analysis. A phylogenetic tree based on the alignment of core genome was constructed using maximum likelihood method with iqtree v. 2.4.0 software. Results. Phylogenetic analysis revealed that five isolates were included in the same cluster as representatives of V. paracholerae, indicating their belonging to this species. V. cholerae non-O1/non-O139 and V. paracholerae strains do not contain the CTXφ and RSIφ prophages, the TLC element, the VPI-1 pathogenicity island, the VSP-I pandemic island, and the ICE SXT element. At the same time, their genomes were found to contain the toxR/toxS genes responsible for the biosynthesis of regulatory proteins that control the production of the main pathogenicity factors; the loci of the type 6 secretion system; the MARTX toxin; mannose-sensitive adhesion pili; the outer membrane protein OmpW; and the hemolysin HlyA. In some strains, altered genes of the type 3 secretion system, the vc0496 gene from the VSP-II pandemicity island, the class 1 CRISPR-cas system, and nanH of the VPI-2 pathogenicity island were detected. Analysis of specific genes confirmed that 5 isolated strains belong to the V. paracholerae species. Conclusion. Not only V. cholerae non-O1/non-O139 strains but also V. paracholerae strains circulate in the Volga River near Saratov. Both groups of strains have similar biochemical properties and genetic makeup. Their genomes lack pathogenicity genes and several pandemic genes, but loci for additional toxins, the presence of which is characteristic of aquatic vibrios, have been identified. Further comparative phenotypic and molecular genetic studies of V. paracholerae are necessary.


  • A Case of Isolation of a Brucella melitensis Strain from a Patient with Infectious Endocarditis in Medical Organization

    by S. A. Portenko, E. A. Bil’kO, A. V. Kazantsev, O. A. Koreshkova, N. A. Osina, K. R. Demakhina, D. A. Sitmbetov, Ya. M. Krasnov, A. D. Katyshev, S. D. Katyshev, et al.

    The aim of the work consisted in verification and detailed identification of the causative agent of brucellosis isolated from a patient diagnosed with infectious endocarditis with extensive tricuspid valve damage. Materials and methods . We investigated the clinical material from the affected person (blood, blood serum) and the obtained culture of brucellosis agent. Medical organization performed tests for sterility of blood using a BC60 hemoculture analyzer. Identification of the grown colonies was carried out on a VITEK® MS mass spectrometer. The Indication Center conducted studies of clinical material samples from the patient and an in-depth study of the Brucella spp. 1079 strain obtained from the medical organization using bacteriological, serological, mass spectrometric, molecular-genetic methods, and high-throughput sequencing. Results and discussion . The strain, primarily identified as Brucella spp., was isolated from a patient’s blood sample in a laboratory at the medical facility. Following in-depth testing at the Indication Center using a combination of phenotypic and molecular biological methods, this strain was verified and assigned to Brucella melitensis genotype IIi. The culture is sensitive to gentamicin, streptomycin, levofloxacin, doxycycline, rifampicin, amikacin, kanamycin, and tetracycline. It is intermediately resistant to nalidixic acid and ciprofloxacin, and is insensitive to ceftriaxone and trimethoprim-sulfamethoxazole. Nucleotide sequences of the omp25 and omp2a genes of Brucella were detected in blood and serum samples from the patient. These sequences confirmed the presence of B. melitensis in the samples. IgM and IgG antibodies to the causative agent of brucellosis were detected in the patient’s blood serum. As a result of the study, the brucellosis agent isolate obtained at the medical facility from a patient diagnosed with infectious endocarditis with extensive tricuspid valve damage was verified and identified as B. melitensis genotype IIi. This case confirms the need for increased awareness among healthcare personnel regarding particularly dangerous infections, as well as coordinated efforts across various agencies.

  • Open Access

    Intraspecific Differentiation of Yersinia pestis Using Mass Spectrometric Analysis

    by A. S. Abdrashitova, A. V. Boiko, N. E. Shcherbakova, E. A. Bil’kO, O. A. Koreshkova, N. S. Chervyakova

    The aim of the study was to evaluate approaches and possibilities for differentiating strains of plague agent of the main and non–main subspecies using the method of mass spectrometric analysis. Materials and methods. 102 strains of Yersinia pestis of 4 subspecies were used in the current work, which were grown on LB agar pH (7.2±0.1) at a temperature of (28±1) °C for (48±1) hours. The mass spectra of the samples were taken automatically with a laser frequency of 60 Hz on a Microflex LT mass spectrometer (Bruker Daltonics, Germany). The spectra were analyzed in the mass range of 2–20 kDa. Results and discussion. Various approaches to the differentiation of plague microbe strains by subspecies (biovars) using the MALDI-TOF mass spectrometry method have been considered. When using visual analysis for the sample under study, it is not possible to select fragments of the proteinogram that could be considered specific signals for each subspecies or biovar of Y. pestis. Using the cluster analysis of the MALDI Biotyper program, the formation of two separate clusters was noted, including the mass spectra of strains of the main and Caucasian subspecies of the plague microbe. The mass spectra of Y. pestis strains of the central asiatica and ulegeica subspecies are not grouped into separate clusters. When evaluating the informative value of peaks in the mass spectra, it was demonstrated that the same peak has a different weight value for different subspecies (biovars). Thus, the possibility of using different approaches in the analysis of protein profiles of Y. pestis strains for their differentiation by subspecies and/or biovars has been examined.

  • Development of Coded Sample Panels for Training of Rospotrebnadzor Specialists and Validation of New Laboratory Techniques

    by Aislu M. Senichkina, Svetlana A. Portenko, Irina N. Sharova, Oksana A. Koreshkova, Ksenia D. Blinova, Natalia A. Osina, Tatiana A. Malyukova

    1. Introduction: Panels of pathogen-containing control samples are necessary for training of specialists of the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor), drills of rapid response teams of specialized anti-epidemic brigades, external quality control of Rospotrebnadzor laboratories by Reference Centers, method validation in laboratories, and participation of Rospotrebnadzor laboratories in proficiency testing (PT) and interlaboratory comparison tests (ICT). Objective: To prepare panels of coded samples of deoxyribonucleic acids (DNA) and complementary DNA (cDNA) of pathogens of highly contagious infectious diseases to be used for training of specialists in Rospotrebnadzor institutions and mobile units and for validation of new laboratory methods. Materials and methods: We used lyophilized samples of rhinovirus and SARS-CoV-2 cDNA and Yersinia pestis, Francisella tularensis, Vibrio cholerae, Brucella suis, and Bacillus anthracis DNA. DNA was obtained from bacterial suspensions of the above microorganisms, cDNA was derived from positive controls contained in reagent kits produced in Russia, and “negative” samples were obtained from embryonic calf serum. All samples were dehydrated with 15 % sucrose solution. Results: We developed panels of control samples to be used for PCR detection of highly contagious bacterial pathogens and the most common viruses. We also established their optimal storage time and temperature. To this end, dehydrated samples were kept at temperatures of +4 °C, +26 °C, +37 °C, and –20 °C during 30 days and tested for stability. The optimal storage times for the samples was determined to be 7 days. The samples were then assembled into panels, adhering to confidentiality principles, and sent to laboratories. Conclusion: The prepared panels of control samples can be used for training of Rospotrebnadzor specialists, including those included in mobile units, in PCR testing and validating new techniques in Rospotrebnadzor laboratories.